NCT04973293 2024-11-19Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung CancerRuijin HospitalPhase NA Recruiting20 enrolled
NCT06421298 2024-05-20A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.Beijing Chest Hospital, Capital Medical UniversityPhase 2 Recruiting30 enrolled